HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process.

In the last decade, pharmaceutical regulatory agencies are focused on monitoring and evaluation of trace-level genotoxic impurities (GTIs) in drug substances, which requires manufacturers to deliver innovative approaches for their analysis and control. GTIs in the low p.p.m. level rising from the process of drug production have to be positively identified and quantified. Therefore, sensitive and selective analytical methods are necessary for required quantification level of these GTIs. Unfortunately, general guidance on how to develop strategy of the analysis and control of GTIs is currently missing in the pharmaceutical industry. Therefore, practical example of the analytical control of 2-chloro-N-(2-chloroethyl)ethanamine GTI in the vortioxetine (VOR) manufacturing process was demonstrated in this work. QDa mass detection with electrospray ionization in selected-ion recording mode was utilized for quantitation of GTIs. The method of hydrophilic interaction liquid chromatography coupled with mass spectrometry detection (HILIC-MS) was validated as per International Conference on Harmonization guidelines and was able to quantitate GTIs at 75 p.p.m. with respect to VOR. The HILIC-MS method was achieved using a Primesep B column (150 × 4.6 mm, 5.0 µm; Sielc, USA) using mobile phase consisting of 10 mM ammonium formate buffer pH 3.0 and acetonitrile (5 : 95, v/v) at 0.8 mL/min flow rate. The QDa mass detector was operated in the positive ion mode. Quadrupole mass analyzer was employed in selected-ion monitoring mode using target ion at m/z 142 as [M+H](+).

[1]  C. Welch,et al.  Evaluation of a compact mass spectrometer for routine support of pharmaceutical chemistry. , 2014, Journal of pharmaceutical and biomedical analysis.

[2]  G. Gresham,et al.  Identification of the nitrogen-based blister agents bis(2-chloroethyl)methylamine (HN-2) and tris(2-chloroethyl)amine (HN-3) and their hydrolysis products on soil using ion trap secondary ion mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[3]  C. Sánchez,et al.  Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: Evidence for direct 5-HT receptor modulation , 2014, European Neuropsychopharmacology.

[4]  C. Halldin,et al.  5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects , 2013, European Neuropsychopharmacology.

[5]  J. Buchbjerg,et al.  Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant , 2013, Clinical Drug Investigation.

[6]  A. Robichaud,et al.  A General and Convenient Synthesis of N‐Aryl Piperazines. , 2006 .

[7]  G. J. Jong,et al.  A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis , 2011, Analytical and bioanalytical chemistry.

[8]  T. Okui,et al.  Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. , 1986, Mutation research.

[9]  R. Hen,et al.  Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice , 2013, Neuropharmacology.

[10]  J. Wolff,et al.  Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API). , 2008, Journal of pharmaceutical and biomedical analysis.

[11]  David Q. Liu,et al.  Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process. , 2009, Journal of pharmaceutical and biomedical analysis.

[12]  D. Elder,et al.  Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[13]  Andrew Teasdale,et al.  ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk , 2017 .

[14]  Jun Wang,et al.  Ultra high performance liquid chromatography coupled with high resolution quantitation mass spectrometry method development and validation for determining genotoxic 2,5-dichlorobenzoyl chloride in MLN9708 drug substance. , 2014, Journal of pharmaceutical and biomedical analysis.

[15]  David Q. Liu,et al.  A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. , 2008, Journal of pharmaceutical and biomedical analysis.

[16]  W. Grimm Stability Testing: Photostability Testing of New Drug Substances and Products , 2021, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.

[17]  David Q. Liu,et al.  Analytical challenges in stability testing for genotoxic impurities , 2013 .

[18]  Christophe Croux,et al.  Linearity of calibration curves: use and misuse of the correlation coefficient , 2002 .

[19]  D. Brusick,et al.  The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1986, Mutation research.

[20]  James A. Baker,et al.  Decontamination of chemical warfare agents , 1992 .

[21]  N V V S S Raman,et al.  Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective. , 2011, Journal of pharmaceutical and biomedical analysis.

[22]  Open access liquid chromatography/tandem mass spectrometry: implementation of a fully quantitative system in a drug discovery laboratory , 2010 .

[23]  R. A. Scott,et al.  Use of 2-mercaptopyridine for the determination of alkylating agents in complex matrices: application to dimethyl sulfate. , 2005, Talanta.